{"nct_id":"NCT05374590","title":"Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis","status":"ENROLLING_BY_INVITATION","status_verified_date":"2025-08","start_date":"2022-08-18","start_date_type":"ACTUAL","primary_completion_date":"2028-09","primary_completion_date_type":"ESTIMATED","completion_date":"2028-09","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["ARGX"]}